Also trades as: PRN.TO (TSX) · $vol 0M
PROF NASDAQ
Profound Medical Corp.
1W: -5.7%
1M: -5.9%
3M: -4.1%
YTD: -12.1%
1Y: +42.9%
3Y: -51.3%
5Y: -62.1%
$6.89
+0.16 (+2.38%)
Weekly Expected Move ±8.4%
$6
$6
$7
$8
$8
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$203.6M
52W Range3.76-8.95
Volume38,494
Avg Volume192,240
Beta0.50
Dividend—
Analyst Ratings
Company Info
CEOArun Swarup Menawat
Employees142
SectorHealthcare
IndustryMedical - Devices
IPO Date2019-10-29
Websiteprofoundmedical.com
2400 Skymark Avenue
Mississauga, ON L4W 5K5
CA
Mississauga, ON L4W 5K5
CA
16474761350
About Profound Medical Corp.
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Latest News
Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?
Profound outlines ~$25M 2026 revenue, anticipates FDA clearance for Siemens Free integration by year-end
Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates
Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates
Profound Medical Corp. Investigated by the Portnoy Law Firm
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Menawat Arun Swarup | P-Purchase | 12,027 | $4.73 | 2025-05-16 |
| Menawat Arun Swarup | P-Purchase | 10,003 | $4.33 | 2025-05-15 |
| HOFER MICHAEL | S-Sale | 40,000 | $0.16 | 2012-12-20 |
| HOFER MICHAEL | P-Purchase | 40,000 | $0.15 | 2012-12-18 |
| TEJADA FRED | P-Purchase | 500,000 | $0.00 | 2012-06-19 |